NCT03414840View on ClinicalTrials.gov

Assessment of Change in Atherosclerotic Plaque by Serial CCTA

UnknownOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

February 28, 2020

Study Completion Date

October 31, 2020

Conditions
Coronary Artery DiseaseHydroxymethylglutaryl-CoA Reductase InhibitorsCoronary Arteriosclerosis
Interventions
DRUG

Atorvastatin

Patients diagnosed with coronary artery disease by CCTA be enrolled. Among enrolled patients, patients who is indicated to statin treatment according to the current ACC/AHA guideline will be treated with atorvastatin.

Trial Locations (1)

120-752

RECRUITING

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul

Sponsors
All Listed Sponsors
collaborator

Chong Kun Dang Pharmaceutical Corp.

INDUSTRY

lead

Yonsei University

OTHER